“Non-viral gene therapy for pancreatic diseases: Advances, challenges, and future prospects”
Non-viral gene therapy holds great potential for the treatment of pancreatic diseases. Unlike viral vectors, non-viral approaches have advantages such as reduced immunogenicity, lower risk of insertional mutagenesis, and greater cargo capacity. Here’s an overview of advances, challenges, and future prospects in non-viral gene therapy for pancreatic diseases: Advances: Challenges: Future Prospects: Non-viral gene therapy…
